Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 267.1 | 136.0 | 49.2 | | | |
| Research and development | | | | 18.8 | 22.0 | 14.1 |
| General and administrative | | | | 7.6 | 3.5 | 3.1 |
| EBIT | 0.0 | 0.0 | 0.0 | -26.4 | -25.5 | -17.2 |
| Pre-tax income | -266.9 | -133.1 | -47.4 | -41.4 | -27.9 | -17.1 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -267.0 | -133.1 | -47.4 | -41.4 | -27.9 | -17.1 |
| |
| Diluted EPS | ($5.16) | ($2.91) | ($1.25) | ($2.77) | ($3.72) | ($2.38) |
| Shares outstanding (diluted) | 51.8 | 45.7 | 37.9 | 15.0 | 7.5 | 7.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|